1 Colovos C, "Verification of protein structures: patterns of nonbonded atomic interactions" 2 : 1511-1519, 1993
2 Moissenet D, "Use of 16S rRNA gene sequencing for identification of “Pseudomonas-like” isolates from sputum of patients with cystic fibrosis" 53 : 500-502, 2005
3 Gross R, "The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic Bordetellae" 9 : 449-, 2008
4 Szklarczyk D, "The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored" 39 : D561-D568, 2011
5 Niu C, "Subinhibitory concentrations of cinnamaldehyde interfere with quorum sensing" 43 : 489-494, 2006
6 Lovell SC, "Structure validation by Calpha geometry:phi,psi and Cbeta deviation" 50 : 437-450, 2003
7 Badger J, "Structure determination of LpxD from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii" 69 (69): 6-9, 2013
8 Buetow L, "Structure and reactivity of LpxD, the N-acyltransferase of lipid A biosynthesis" 104 : 4321-4326, 2007
9 Nogi M, "Septic arthritis and osteomyelitis due to Bordetella petrii" 53 : 1024-1027, 2015
10 Damte D, "Putative drug and vaccine target protein identification using comparative genomic analysis of KEGG annotated metabolic pathways of Mycoplasma hyopneumoniae" 102 : 47-56, 2013
1 Colovos C, "Verification of protein structures: patterns of nonbonded atomic interactions" 2 : 1511-1519, 1993
2 Moissenet D, "Use of 16S rRNA gene sequencing for identification of “Pseudomonas-like” isolates from sputum of patients with cystic fibrosis" 53 : 500-502, 2005
3 Gross R, "The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic Bordetellae" 9 : 449-, 2008
4 Szklarczyk D, "The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored" 39 : D561-D568, 2011
5 Niu C, "Subinhibitory concentrations of cinnamaldehyde interfere with quorum sensing" 43 : 489-494, 2006
6 Lovell SC, "Structure validation by Calpha geometry:phi,psi and Cbeta deviation" 50 : 437-450, 2003
7 Badger J, "Structure determination of LpxD from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii" 69 (69): 6-9, 2013
8 Buetow L, "Structure and reactivity of LpxD, the N-acyltransferase of lipid A biosynthesis" 104 : 4321-4326, 2007
9 Nogi M, "Septic arthritis and osteomyelitis due to Bordetella petrii" 53 : 1024-1027, 2015
10 Damte D, "Putative drug and vaccine target protein identification using comparative genomic analysis of KEGG annotated metabolic pathways of Mycoplasma hyopneumoniae" 102 : 47-56, 2013
11 Kelley LA, "Protein structure prediction on the Web: a case study using the Phyre server" 4 : 363-371, 2009
12 Wiederstein M, "ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins" 35 : W407-W410, 2007
13 Anishetty S, "Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis" 29 : 368-378, 2005
14 Haag NL, "Potential antibacterial targets in bacterial central metabolism" 4 : 21-32, 2012
15 Jalal Z, "Phytochemistry of the essential oil of Melissa officinalis L. growing wild in Morocco: preventive approach against nosocomial infections" 5 : 458-461, 2015
16 Hu J, "Multicenter prospective epidemiological studies on Haemophilus influenzae infection among hospitalized children with lower respiratory tract infections" 54 : 119-125, 2016
17 Barb AW, "Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis" 9 : 9-15, 2008
18 Wang X, "Lipopolysaccharide: biosynthetic pathway and structure modification" 49 : 97-107, 2010
19 Rosenfeld Y, "Lipopolysaccharide (Endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis" 1758 : 1513-1522, 2006
20 Kanehisa M, "KEGG as a reference resource for gene and protein annotation" 44 (44): D457-D462, 2016
21 Wang F, "Isolation and characterization of 1,2,4-trichlorobenzene mineralizing Bordetella sp. and its bioremediation potential in soil" 67 : 896-902, 2007
22 Namkung W, "Inhibition of Ca2+-activated Cl- channels by gallotannins as a possible molecular basis for health benefits of red wine and green tea" 24 : 4178-4186, 2010
23 In Silico Biol, "In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae" 9 : 225-231, 2009
24 Ravindranath BS, "In silico analyses of metabolic pathway and protein interaction network for identification of next gen therapeutic targets in Chlamydophila pneumoniae" 9 : 605-609, 2013
25 Xu D, "Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization" 101 : 2525-2534, 2011
26 Chowdhury SP, "Identification of diazotrophs in the culturable bacterial community associated with roots of Lasiurus sindicus, a perennial grass of Thar Desert, India" 54 : 82-90, 2007
27 Spilker T, "Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis" 14 : 504-506, 2008
28 Shanmugham B, "Identification and characterization of potential therapeutic candidates in emerging human pathogen Mycobacterium abscessus: a novel hierarchical in silico approach" 8 : e59126-, 2013
29 Alshalchi SA, "Expression of the lipopolysaccharide biosynthesis gene lpxD affects biofilm formation of Pseudomonas aeruginosa" 197 : 135-145, 2015
30 Manaswini Jagadeb, "Elucidation of the Inhibitory Effect of Phytochemicals with Kir6.2 Wild-Type and Mutant Models Associated in Type-1 Diabetes through Molecular Docking Approach" 한국유전체학회 12 (12): 283-288, 2014
31 Satish Kumar, "Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis" 한국유전체학회 12 (12): 64-70, 2014
32 Moghaddam SJ, "Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice" 30 : 1949-1956, 2009
33 Niu C, "Colorimetric method for identifying plant essential oil components that affect biofilm formation and structure" 70 : 6951-6956, 2004
34 Pandey M, "Choke point analysis with subtractive proteomic approach for insilico identification of potential drug targets in Shigella dysenteriae" 109 : 29-34, 2015
35 Wallner B, "Can correct protein models be identified?" 12 : 1073-1086, 2003
36 von Wintzingerode F, "Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella" 51 (51): 1257-1265, 2001
37 Le Coustumier A, "Bordetella petrii infection with long-lasting persistence in human" 17 : 612-618, 2011
38 Stark D, "Bordetella petrii from a clinical sample in Australia: isolation and molecular identification" 56 (56): 435-437, 2007
39 Fry NK, "Bordetella petrii clinical isolate" 11 : 1131-1133, 2005
40 LeFrock J, "Bone and joint infections caused by gram-positive bacteria: treatment with cefotaxime" 13 (13): S50-S55, 1985
41 Bianchi F, "Bioremediation of toluene and naphthalene: development and validation of a GC-FID method for their monitoring" 95 : 515-524, 2005
42 Morris GM, "AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility" 30 : 2785-2791, 2009
43 Flores G, "Antioxidants of therapeutic relevance in COPD from the neotropical blueberry Anthopterus wardii" 131 : 119-125, 2012
44 Conway SP, "Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis" 2 : 321-332, 2003
45 Gómez-Cerezo J, "Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases" 22 : 360-363, 2003
46 Vetrivel U, "A novel in silico approach to identify potential therapeutic targets in human bacterial pathogens" 5 : 25-34, 2011
47 Sakharkar KR, "A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa" 4 : 355-360, 2004
48 Sfanos K, "A molecular systematic survey of cultured microbial associates of deep-water marine invertebrates" 28 : 242-264, 2005